Industry Focus

A new report predicts that banks are likely to lose as much as $280 billion of their payments revenue by 2025, thanks to fintech disruption from companies like Square (NYSE: SQ), PayPal (NASDAQ: PYPL), and others. Here’s why investors may want to take notice, and one new way Square is trying to capitalize on its growing payments platform. Plus, Industry Focus: Financials host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss The Motley Fool’s new real estate investing brand Millionacres and share the latest stocks on their watch lists.  

Tech: Apple’s Big DayWe’ve set our eyes on the new iDevices! Apple has a refresh of its iPad, iPhone and Watch products, but those new developments have taken a backseat to the company’s larger commitment to streaming services. We dig into the news and what it means for Apple and the other streaming players.

Stocks: AAPL, NFLX

Earlier this month, FedEx announced that it would no longer provide domestic express service to Amazon. What does this breakup mean for Amazon, e-commerce, and the future of logistics? Motley Fool Contributor Dan Kline joins the show to answer this question and more on this week’s episode of Industry Focus: Energy & Industrials.

Stocks Mentioned: KTOS, BA, GD, HII, LMT, TXT 

Check out more of our content here:

StockUp, The Motley Fool's weekly email newsletter

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

Acadia Pharmaceuticals' dementia-related psychosis trial offers new hope to patients diagnosed with Alzheimer's disease.  Also, results from a lung cancer trial just strengthened Eli Lilly's leadership in precision medicine.

Stocks: ACAD, LLY

The retail-pocalypse has scared a lot of investors out of investing in any of the major names you see in malls, but what if we said there was a way to play retail that didn't bank as much on the success of stores like Macy's? Today we talk about the shopping mall REITs, how their business models are changing a bit, and which ones might be worth putting on your watch list.

Stocks: SPG, MAC, TCO, BPR

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

In this week’s installment of Industry Focus: Financials, president of Prudential (NYSE: PRU) retirement Phil Waldeck talks with host Jason Moser and Robert Brokamp, CFP about the state of retirement in the United States and more. Then, Moser and Fool.com contributor Matt Frankel, CFP dive into DocuSign’s (NASDAQ: DOCU) excellent quarter and the future growth potential of the company. Plus, in a brand new segment, Moser and Frankel each discuss the last stock each of them bought in their own portfolios and why. And finally, the pair give listeners the stocks that are at the top of their watch lists. All of this and more on this week’s episode.

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

We talk about results from Slack, the workplace messaging SaaS company. In a vacuum, the company's results were strong, but stacked against past growth rates, they show things are slowing down a bit. In fact, Slack's struggle is an all-too-common one for the class of 2019 IPOs.

Stocks: WORK, UBER, PINS

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Zillow was one of the earliest movers to disrupt real estate via technology, but it’s taking an even bigger step with its Zillow Offers iBuyer program. Motley Fool Contributor Luis Sanchez joins the podcast to take a look at how Zillow has fared so far and where the market might be headed. 

Stocks Mentioned: Z, ZG, RDFN

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Amgen's $13.4 billion cash offer has won the bidding war for Celgene and Bristol-Myers Squibb's psoriasis drug, Otezla. Here's why the Goliath biopharma is betting so big on its success. Also, new data from The Medicines Company suggests a new cholesterol-busting drug is on it's way to approval. Stocks: CELG, BMY, AMGN, MDCO

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter

Last week, Papa John’s hired Arby’s President Rob Lynch as its new CEO. This continues an ongoing evolution of the company as it moves on from its relationship with founder John Schnatter. Motley Fool Contributor Dan Kline joins the show to discuss the hire and how it fits into the company’s turnaround plans. 

Stocks Mentioned: PZZA, DPZ, DRI

Check out more of our content here:

• TMF's podcast portal
• YouTube
• Twitter
• Join Our Motley Fool Podcast Facebook Group
• LinkedIn
• StockUp, The Motley Fool's weekly email newsletter